RoC Skincare is moving into a larger study of its Patented Clinical Retinol using identical twins and wearable biometric data, an approach the company says can sharpen its understanding of how lifestyle and skin care interact.
The brand is recruiting 30 pairs of adult female identical twins aged 40 and older who live in the United States. Participants will follow a study regimen for 12 weeks while wearing an Oura Ring, which tracks sleep, stress, heart rate, heart-rate variability and temperature trends. RoC will pair those readings with standard clinical skin assessments, including expert grading, digital photography, corneometer readings and participants' own evaluations.
A natural control
Identical twins share DNA and much of their early environment, making them a useful comparison for skin-aging research. Art Pellegrino, RoC Skincare's chief scientific officer, said that when two people start with the same genetic blueprint, differences between them are harder to attribute to genetics. That, he said, makes it easier to see what the retinol is doing on the skin.
Pellegrino described the earlier pilot as an effort to prove the model and determine whether identical twins could offer a more precise way to study the drivers of visible skin aging. He said the answer was yes. Because twins act as a close natural control, researchers can more confidently examine whether lifestyle and environment explain divergent skin outcomes.
Pilot findings and limits
In the pilot, Pellegrino said twins in the placebo group had similar or worse signs of aging by the end of the study, while twins in the treatment group showed as much as or more than 20% improvement in four weeks. The pilot compared a treatment group with a placebo group; it did not attempt to quantify how much skin aging comes from genes versus lifestyle.
The expanded study is designed to examine that question. RoC wants to see how daily life, particularly sleep and stress, can change the picture when genetics are held constant. Pellegrino said the combination of twins and wearable tracking should allow the company to compare how one sister's skin responds to the regimen when she is sleeping poorly or under more stress than the other.
For example, RoC expects the data to show whether weeks of poor sleep line up with lower hydration readings, or whether the twin with lower stress sees fine lines improve faster. The company is also interested in the reverse question: whether participants who see visible skin improvements also feel less stressed.
Recruitment and measurement
RoC acknowledges that it cannot guarantee twins have identical external influences, such as sun exposure or diet. The company is recruiting twins with similar levels of environmental damage where possible and tracking sleep and stress closely throughout the study.
Pellegrino said wearables are opening an opportunity across the industry to factor in how people live when recommending skin care. By controlling for genetic differences through twins and tracking lifestyle parameters directly, RoC expects to quantify external stressors and their relationship to skin condition.
The company expects results from the twin study by mid-2027. Pellegrino said the findings will shape how RoC develops products for skin longevity and how it designs future clinical studies. The 12-week, 30-pair phase is intended as one stage in a longer research program on extending skin span, or how long skin keeps looking its best.
